S ilenCircleTM RNAi system (pro- tected under US patent 7,294,504 and additional patents pending) is Box 1 | Product Summary a plasmid-based RNA interference Catalogue Numbers ABP-RI-SC04010 (10 rxns) system that uses engineered human ABP-RI-SC04020 (20 rxns) U6 RNApolymerase III promoter and modified terminator for high level Components Pre-Cut pSIlenCircle Vector also expressing small hairpin RNA (shRNA) or siRNA mTFP1 (10ng/µl) expression inside mammalian cells. pSilenCircle sequencing Primer (20µM) The design enables precise start and p53-top (coding for p53 RNAi insert top strand) end of an interfering RNA with the op- (20µM) timal 3’ overhanging nucleotides. The p53-bot (coding for p53 RNAi insert bottom pre-cut linear vector is ready-to-ligate strand) (20µM) for construction of interfering RNA ex- Storage All reagents to be stored at -20°C. pression plasmid with nearly zero self- ligation. Bearing a neomycin resistant Stability All components are stable for 6 months when stored properly. marker, it may be used for establish- ing siRNA-expressing stable cell lines. It alslo contains an mTFP1 marker for FP analysis. SilenCircle RNAi system Reagents Provided with has been successfully used to knock- the Kit Design of Inserts down expression of both endogenous and exogenous genes. siRNA may be produced from two pSilenCircle plasmids encoding either
T he kit provides enough reagents sense or antisense. Alternatively,
Features shRNA or miRNA may be produced to construct 10 or 20 RNAi from a single plasmid (shown below). T he SilenCircletm mTFP1 plus expressing plasmids, including Allele recombinant high concentration T4 For each siRNA insert, two comple- Basic RNAi kit is suitable for DNA ligase (hcT4 DNA ligase). DNA mentary synthetic DNA oligos are RNAi experiments in tissue culture oligos encoding each RNAi target needed. cells. Each batch of reagents is vigorously tested for consistency sequence need to be designed according to the guidelines listed Choose a target region that is A2N19 and stability, and offer the following below. (sense sequence of the target RNA), features: design a linker sequence (e.g. 9 - Efficient RNA interference bases), use the following format: Oligos for generating p53-specific - Convenient ready-to-ligate format RNAi cassettes that have been tested - Almost no background ligation to significantly reduce p53 mRNA 5’ acacc N19 Linker N’19 t 3’ - Without introducing extra bases levels are also included as positive 3’ g N’19 rcLinker N19 aaaaa 5’ # from restriction enzyme sites, control. generate precise shRNA, siRNA, or “N’19” is reverse/complementary to miRNA. “N19”; “rclinker” is reverse/ comple- The Basic Kit also provides RT-PCR mentary to “linker”. primers for detecting p53 and actin Materials Not Suppplied mRNA levels are also included in the # Oligos orders are typically entered Complete Kit. A successful p53 RNAi with the Kit from 5’ to 3’, i.e. aaaaa N19... experiment is expected to result in reduced p53 mRNA levels while not Note: This product may be protected -Target-specific insert DNA oligos affecting actin mRNA levels. RT-PCR under US patent 7,294,504 and additional -E. coli competent cells with p53 primers should generate a pending patents. Purchasing of this prod- -Plasmid DNA purification system band of 496 bp; RT-PCR with actin uct grants the rights of use. Commercial primers results in a band of 587b. user may be required to obtain further -RNA purification system and reverse license from third parties in order to use transcription enzyme. certain RNA interference related technolo- -Annealing buffer (10X) gies. -hcT4 DNA ligase with 10X buffer -AvantGene Transfection Reagent -DNA dilutent -5’ and 3’ p53 PCR primers -5’ and 3’ Actin PCR primers
Allele Biotech-Introducing Cost Effectiveness to Research
Protocols Cloning Transfection Oligo DNA annealing, ligation into the linearized vector, E. Cells are prepared and transfected generally as you coli transformation, and plasmid DNA preparation may be would with a typical expression plasmid transfection. Most performed according to standard protocols. Plasmid DNA commercial transfection reagents may be used with the from positive clones will be cut only once by restriction SilenCircleTM plasmids. Although using AvantGene trans- enzyme Stu I on the plasmid backbone (The Stu I site in fection reagent is recommended, in many cases the choice the Polylinker should have been deleted from the pre-cut of transfection reagent should depend on cells to be used. vector). A self-ligation plasmid (from the very few molecules Use 0.5 μg plasmid DNA per well of a 24-well plate as a that escaped linearization of the vector) will yield two bands starting point. of 1.1 kb and 3.5 kb, respectively. A sequencing primer is also included in the kit for positive clone verification.
Suggested Protocol for siRNA Insert Prepa-
F or Research Use Only. Not for Diagnostic or Therapeutic Use. Purchase does not include or carry ration any right to resell or transfer this product either as a stand-alone product or as a component of another Top oligo 1μg product. Any use of this product other Bottom Oligo 1μg than the permitted use without the express written authorization of Allele Annealing Buffer (10X) 2μl Biotech is strictly prohibited Distilled Water 20μl
Heat at 95°C for 10min, slowly cool down to room tempera-